Skip to main content
Eli Lilly and Company (SWX:LLY)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
675.00
0.00 (0.00%)
At close: Apr 23, 2025

Eli Lilly and Company Revenue

In the year 2024, Eli Lilly and Company had annual revenue of $45.04B USD with 32.00% growth. Eli Lilly and Company had revenue of $13.53B in the quarter ending December 31, 2024, with 44.68% growth.

Revenue
$45.04B
Revenue Growth
+32.00%
P/S Ratio
15.06
Revenue / Employee
$958.36K
Employees
47,000
Market Cap
614.72B CHF

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202445.04B10.92B32.00%
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 202024.54B2.22B9.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 62.40B
Novartis AG 46.87B
Lonza Group AG 6.57B
Alcon 8.98B
Galderma Group AG 4.02B
Straumann Holding AG 2.50B
Sonova Holding AG 3.71B
Sandoz Group AG 9.41B
Revenue Rankings

Eli Lilly and Company News

More News